rosiglitazone has been researched along with lg 100268 in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 11 (78.57) | 29.6817 |
2010's | 1 (7.14) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
Ardecky, RJ; Boehm, MF; Chen, JH; D'Arrigo, J; Grese, TA; Karanewsky, DS; Leibowitz, MD; Liu, S; Mais, DA; Mapes, CM; Michellys, PY; Montrose-Rafizadeh, C; Ogilvie, KM; Reifel-Miller, A; Rungta, D; Thompson, AW; Tyhonas, JS | 1 |
Bischoff, ED; Boehm, MF; Cesario, RM; Crombie, DL; Davies, PJ; Hamann, LG; Heyman, RA; Jow, L; Mondon, CE; Mukherjee, R; Nadzan, AM; Paterniti, JR | 1 |
Cawthorne, MA; Crombie, DL; Heyman, RA; Hislop, DC; Liu, YL; Sennitt, MV | 1 |
Blanchard, SG; Gribble, GW; Honda, T; Leesnitzer, LM; Mangelsdorf, DJ; Plunket, KD; Porter, WW; Sporn, MB; Suh, N; Wang, Y; Willson, TM | 1 |
Cawthorne, MA; Emilsson, V; Heyman, R; Liu, YL; O'Dowd, J; Sennitt, M; Wang, S | 1 |
Boehm, M; Crombie, DL; Davies, PJ; Depre, C; Heyman, RA; Leibowitz, MD; Liu, S; Nagy, L; Singh Ahuja, H; Tontonoz, P | 1 |
Akanuma, Y; Ezaki, O; Fukayama, M; Hori, W; Ide, T; Itai, A; Kadowaki, T; Kagechika, H; Kamon, J; Kato, S; Kimura, S; Komeda, K; Kubota, N; Miki, H; Motojima, K; Murakami, K; Nagai, R; Shudo, K; Terauchi, Y; Tobe, K; Tsuboyama-Kasaoka, N; Tsuchida, A; Waki, H; Yamauchi, N; Yamauchi, T | 1 |
Charlton, SJ; Clapham, JC; Coxon, P; Macphee, CH; Marshall, IC; Moore, GB; Moores, K; Newman, SJ; Patel, L; Smith, SA | 1 |
Blows, F; O'Rahilly, S; Sewter, CP; Vidal-Puig, A | 1 |
Domann, FE; Girnun, GD; Moore, SA; Robbins, ME | 1 |
Cline, GW; Davies, PJ; Leibowitz, MD; Shen, Q; Shulman, GI | 1 |
Brinckerhoff, CE; Burrage, PS; Ren, Y; Schmucker, AC; Sporn, MB | 1 |
Decsi, T; Liebisch, G; Marosvölgyi, T; Mihály, J; Rühl, R; Schmitz, G; Weiss, K | 1 |
Jiang, XY; Wang, SY; Xiao, O; Yang, PS; Yang, SJ; Yu, K; Zhou, SY | 1 |
14 other study(ies) available for rosiglitazone and lg 100268
Article | Year |
---|---|
Design, synthesis, and structure-activity relationship studies of novel 6,7-locked-[7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta]-2,4,6-trienoic acids.
Topics: Alkenes; Animals; Benzene Derivatives; Caprylates; Cell Line; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Design; Drug Synergism; Hypoglycemic Agents; Male; Mice; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Retinoic Acid; Retinoid X Receptors; Rosiglitazone; Structure-Activity Relationship; Thiazoles; Thiazolidinediones; Thyroxine; Transcription Factors; Transfection; Triglycerides | 2003 |
Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists.
Topics: Animals; Bexarotene; Blood Glucose; Cells, Cultured; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Insulin Resistance; Ligands; Mice; Mice, Inbred C57BL; Mice, Obese; Nicotinic Acids; Obesity; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Rosiglitazone; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors; Transfection | 1997 |
Retinoid X receptor agonists have anti-obesity effects and improve insulin sensitivity in Zucker fa/fa rats.
Topics: Analysis of Variance; Animals; Blood Glucose; Body Weight; Eating; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Nicotinic Acids; Obesity; Rats; Rats, Zucker; Receptors, Retinoic Acid; Retinoid X Receptors; Rosiglitazone; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors | 2000 |
A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma.
Topics: 3T3 Cells; Adipocytes; Animals; Cell Differentiation; CREB-Binding Protein; Drug Synergism; Ligands; Methylation; Mice; Nicotinic Acids; Nuclear Proteins; Nuclear Receptor Co-Repressor 1; Oleanolic Acid; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Repressor Proteins; Retinoid X Receptors; Rosiglitazone; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Trans-Activators; Transcription Factors; Transcriptional Activation | 2000 |
The effects of rexinoids and rosiglitazone on body weight and uncoupling protein isoform expression in the Zucker fa/fa rat.
Topics: Adipose Tissue, Brown; Animals; Body Weight; Carrier Proteins; Eating; Ion Channels; Membrane Proteins; Membrane Transport Proteins; Mitochondrial Proteins; Nicotinic Acids; Obesity; Proteins; Rats; Rats, Zucker; Receptors, Retinoic Acid; Retinoid X Receptors; RNA, Messenger; Rosiglitazone; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors; Uncoupling Protein 1; Uncoupling Protein 2; Uncoupling Protein 3; Weight Gain | 2000 |
Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents.
Topics: Adipose Tissue; Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Experimental; Disease Models, Animal; Gene Expression; Glucose Tolerance Test; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Liver; Male; Muscle, Skeletal; Nicotinic Acids; Obesity; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; RNA, Messenger; Rosiglitazone; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors | 2001 |
Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes.
Topics: 3T3 Cells; Adipose Tissue; Animals; Benzhydryl Compounds; Benzoates; Biphenyl Compounds; Diabetes Mellitus, Type 2; Epoxy Compounds; Fatty Acids; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Leptin; Mice; Mice, Knockout; Nicotinic Acids; Obesity; Receptors, Adrenergic, beta-3; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Rosiglitazone; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors | 2001 |
PPARgamma is not a critical mediator of primary monocyte differentiation or foam cell formation.
Topics: ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; CD36 Antigens; Cell Differentiation; Cells, Cultured; DNA-Binding Proteins; Dose-Response Relationship, Drug; Flow Cytometry; Foam Cells; Humans; Interleukin-6; Ligands; Light; Lipoproteins, LDL; Liver X Receptors; Macrophages; Matrix Metalloproteinase 9; Monocytes; Nicotinic Acids; Oligonucleotides, Antisense; Orphan Nuclear Receptors; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; RNA, Messenger; Rosiglitazone; Scattering, Radiation; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors | 2002 |
Regional differences in the response of human pre-adipocytes to PPARgamma and RXRalpha agonists.
Topics: Adipocytes; Adult; Aged; Cell Differentiation; Female; Gene Expression; Humans; Hypoglycemic Agents; Ligands; Male; Middle Aged; Nicotinic Acids; Omentum; Polymerase Chain Reaction; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; RNA, Messenger; Rosiglitazone; Skin; Stem Cells; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors | 2002 |
Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter.
Topics: Animals; Anticholesteremic Agents; Base Sequence; Catalase; Dimerization; Free Radical Scavengers; Gene Deletion; Gene Expression; Molecular Sequence Data; Mutagenesis; Organic Chemicals; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Repetitive Sequences, Nucleic Acid; Response Elements; Retinoid X Receptors; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transfection | 2002 |
Effects of rexinoids on glucose transport and insulin-mediated signaling in skeletal muscles of diabetic (db/db) mice.
Topics: Acyl Coenzyme A; Animals; Anticholesteremic Agents; Biological Transport; Blotting, Western; Body Weight; Cattle; Deoxyglucose; Diabetes Mellitus, Experimental; Glucose; Insulin; Insulin Resistance; Ligands; Ligases; Mice; Muscle, Skeletal; Muscles; Organic Chemicals; Phosphorylation; Precipitin Tests; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-cbl; Receptor, Insulin; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcription Factors; Triglycerides; Tyrosine; Ubiquitin-Protein Ligases | 2004 |
Retinoid X receptor and peroxisome proliferator-activated receptor-gamma agonists cooperate to inhibit matrix metalloproteinase gene expression.
Topics: Animals; Cattle; Cell Line, Tumor; Chondrocytes; Drug Combinations; Gene Expression Regulation, Enzymologic; Humans; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Organic Chemicals; PPAR gamma; Retinoid X Receptors; Rosiglitazone; Thiazolidinediones | 2008 |
Effect of synthetic ligands of PPAR α, β/δ, γ, RAR, RXR and LXR on the fatty acid composition of phospholipids in mice.
Topics: Acetyltransferases; Animals; Benzoates; Butyrates; Fatty Acid Elongases; Fatty Acids; Female; Gene Expression; Hydrocarbons, Fluorinated; Liver; Liver X Receptors; Mice; Mice, Inbred C57BL; Organic Chemicals; Orphan Nuclear Receptors; Peroxisome Proliferator-Activated Receptors; Phenylurea Compounds; Phospholipids; Receptors, Retinoic Acid; Rosiglitazone; Stearoyl-CoA Desaturase; Sulfonamides; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones | 2011 |
Effects of PPAR-γ and RXR-α on mouse meibomian gland epithelial cells during inflammation induced by latanoprost.
Topics: Animals; Anti-Inflammatory Agents; Chemokines; Cyclooxygenase 2; Cytokines; Epithelial Cells; Inflammation; Interleukin-6; Keratin-1; Keratin-17; Latanoprost; Matrix Metalloproteinase 9; Meibomian Glands; Mice; Ophthalmic Solutions; PPAR gamma; Retinoid X Receptor alpha; RNA, Messenger; Rosiglitazone; Tumor Necrosis Factor-alpha | 2022 |